Amy VandenBerg

Amy VandenBerg

No open positions remaining
50 year
Health Technology
Consumer Services

Profile

Amy VandenBerg worked as a Vice President of Regulatory and Clinical Affairs at Obalon Therapeutics, Inc. from 2014 to 2019.
Prior to that, she worked as a Director of Regulatory Affairs at DexCom, Inc. from 2006 to 2008 and as a Manager of Clinical Trials at Cygnus, Inc. Additionally, she earned an undergraduate degree from St. Mary's College of California in 1998.

Former positions of Amy VandenBerg

CompaniesPositionEnd
DEXCOM, INC. General Counsel 01/12/2008
Corporate Officer/Principal -
VYOME HOLDINGS, INC. Chief Tech/Sci/R&D Officer -
See the detail of Amy VandenBerg's experience

Training of Amy VandenBerg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies4

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Stock Market
  2. Insiders
  3. Amy VandenBerg
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!